DrugCite
Search

ZYPREXA RELPREVV

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Zyprexa Relprevv Adverse Events Reported to the FDA Over Time

How are Zyprexa Relprevv adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Zyprexa Relprevv, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Zyprexa Relprevv is flagged as the suspect drug causing the adverse event.

Most Common Zyprexa Relprevv Adverse Events Reported to the FDA

What are the most common Zyprexa Relprevv adverse events reported to the FDA?

Hospitalisation
102 (13.3%)
Agitation
25 (3.26%)
Sedation
25 (3.26%)
Overdose
20 (2.61%)
Psychotic Disorder
17 (2.22%)
Schizophrenia
17 (2.22%)
Aggression
16 (2.09%)
Death
16 (2.09%)
Dysarthria
16 (2.09%)
Drug Dose Omission
13 (1.69%)
Dizziness
12 (1.56%)
Show More Show More
Drug Ineffective
11 (1.43%)
Gait Disturbance
11 (1.43%)
Somnolence
11 (1.43%)
Disorientation
10 (1.3%)
Abnormal Behaviour
9 (1.17%)
Feeling Of Body Temperature Change
9 (1.17%)
Muscular Weakness
9 (1.17%)
Restlessness
9 (1.17%)
Akathisia
8 (1.04%)
Confusional State
8 (1.04%)
Fatigue
8 (1.04%)
Vision Blurred
8 (1.04%)
Anxiety
7 (.91%)
Ataxia
7 (.91%)
Hallucination, Auditory
7 (.91%)
Delirium
6 (.78%)
Influenza
6 (.78%)
Injection Site Haemorrhage
6 (.78%)
Mental Disorder
6 (.78%)
Motor Dysfunction
6 (.78%)
Muscle Twitching
6 (.78%)
Musculoskeletal Stiffness
6 (.78%)
Psychiatric Decompensation
6 (.78%)
Tremor
6 (.78%)
Weight Increased
6 (.78%)
White Blood Cell Count Decreased
6 (.78%)
Asthenia
5 (.65%)
Hypoaesthesia
5 (.65%)
Insomnia
5 (.65%)
Loss Of Consciousness
5 (.65%)
Mania
5 (.65%)
Blood Pressure Decreased
4 (.52%)
Brain Death
4 (.52%)
Drooling
4 (.52%)
Drug Abuse
4 (.52%)
Drug Effect Decreased
4 (.52%)
Hallucination
4 (.52%)
Neuroleptic Malignant Syndrome
4 (.52%)
Neutrophil Count Decreased
4 (.52%)
Obstructive Airways Disorder
4 (.52%)
Pyrexia
4 (.52%)
Schizoaffective Disorder
4 (.52%)
Swollen Tongue
4 (.52%)
Unresponsive To Stimuli
4 (.52%)
Weight Decreased
4 (.52%)
Blood Pressure Increased
3 (.39%)
Cardiac Arrest
3 (.39%)
Cardiac Disorder
3 (.39%)
Chest Pain
3 (.39%)
Chills
3 (.39%)
Delusion
3 (.39%)
Diplopia
3 (.39%)
Extrapyramidal Disorder
3 (.39%)
Fall
3 (.39%)
Gastrointestinal Haemorrhage
3 (.39%)
Hypotension
3 (.39%)
Lung Neoplasm Malignant
3 (.39%)
Paranoia
3 (.39%)
Poor Quality Sleep
3 (.39%)
Road Traffic Accident
3 (.39%)
Tachycardia
3 (.39%)
Urinary Tract Infection
3 (.39%)
Aspartate Aminotransferase Increase...
2 (.26%)
Blood Cholesterol Increased
2 (.26%)
Blood Glucose Increased
2 (.26%)
Blood Lactate Dehydrogenase Increas...
2 (.26%)
Blood Triglycerides Increased
2 (.26%)
Cholelithiasis
2 (.26%)
Contusion
2 (.26%)
Cyanosis
2 (.26%)
Delusion Of Grandeur
2 (.26%)
Depression
2 (.26%)
Disturbance In Social Behaviour
2 (.26%)
Drug Administered At Inappropriate ...
2 (.26%)
Drug Interaction
2 (.26%)
Eosinophil Count Increased
2 (.26%)
Gastrointestinal Disorder
2 (.26%)
Hallucination, Visual
2 (.26%)
Hunger
2 (.26%)
Hypertension
2 (.26%)
Hyponatraemia
2 (.26%)
Impulsive Behaviour
2 (.26%)
Inappropriate Affect
2 (.26%)
Injection Site Abscess
2 (.26%)
Injection Site Erythema
2 (.26%)
Injection Site Induration
2 (.26%)
Intentional Drug Misuse
2 (.26%)
Lymphocyte Count Decreased
2 (.26%)
Mechanical Ventilation
2 (.26%)
Medication Error
2 (.26%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Zyprexa Relprevv, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zyprexa Relprevv is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Zyprexa Relprevv

What are the most common Zyprexa Relprevv adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Zyprexa Relprevv, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zyprexa Relprevv is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Zyprexa Relprevv According to Those Reporting Adverse Events

Why are people taking Zyprexa Relprevv, according to those reporting adverse events to the FDA?

Schizophrenia
80
Schizophrenia, Paranoid Type
17
Schizoaffective Disorder
16
Psychotic Disorder
4
Schizoaffective Disorder Bipolar Ty...
3
Bipolar Disorder
2
Show More Show More
Bipolar I Disorder
2

Drug Labels

LabelLabelerEffective
ZyprexarelprevvEli Lilly and Company17-DEC-12

Zyprexa Relprevv Case Reports

What Zyprexa Relprevv safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Zyprexa Relprevv. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Zyprexa Relprevv.